Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of a lyophilized herpes zoster mRNA vaccine in adults aged 40 years and older
CTR20254264Phase 2Active
- Sponsor
- Abogen Bioscience
- Start
- Nov 2025
- Countries
- 1
01
Overview
A Phase 2 trial of lyophilized herpes zoster mRNA vaccine in herpes zoster (HZ), sponsored by Abogen Bioscience. Started Nov 2025; status: active.
02
Drugs
lyophilized herpes zoster mRNA vaccine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20254264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254264.